Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice

Wei Yan(Shihezi University), Tingting Tang(Chongqing Academy of Forestry), Jiake Xu(Shenzhen Institutes of Advanced Technology), Lin Du(Guiyang Medical University), Haowei Li(Columbia University Irving Medical Center), Zanjing Zhai(Shanghai Jiao Tong University), Tingyu Wang(Shanghai Jiao Tong University), Qiming Fan(Sun Yat-sen University)
Acta Pharmacologica Sinica
January 1, 2014
10.1038/aps.2013.152
Cited by 38

Related Papers

Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
|Nature Medicine|2011|351
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
|Annals of the Rheumatic Diseases|2020|301
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
|Theranostics|2019|252